Autosomal Recessive RPE65-Deficient Leber Congenital Amaurosis

Topic outline

• 

  Grand Rounds

  A 17-year-old male with a biallelic RPE65 mutation resulting in autosomal recessive Leber Congenital Amaurosis is referred for evaluation for subretinal gene therapy with voretigene neparvovec-rzyl. Baseline evaluation was remarkable for severe nyctalopia and limited peripheral vision with VA 20/50 bilaterally. The patient underwent bilateral pars plana vitrectomy and subretinal gene therapy. At 3 and 4 weeks postoperatively, the patient was found to have VA 20/40 and 20/50 in the right and left eyes, respectively. He referred significant overall functional improvement as well as improved night vision. No major complications occurred in the short-term follow up. Subretinal voretigene neparvovec-rzyl may provide improvement in overall function, central vision, and may result in slower disease progression in adult patients with RPE65 Leber Congenital Amaurosis.
  

  Presentation Date: 09/20/2018
  Issue Date: 08/01/2020
  

  • Presenter: Jose J. Echegaray, MD URL
  • Faculty Discussant: Janet L. Davis, MD URL
  • Faculty Discussant: Ninel Z. Gregori, MD URL
  • Faculty Discussant: Byron L. Lam, MD URL
  • Continuing Medical Education (CME)
    

  • If you would like to get CME credits (0.25 AMA PRA Category 1 Credits™) for this lecture, please click here
    

  • Non-CME
    

  • Please click here if you don't want CME credits.